Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT03950154	TitleEstudio de la combinación de quimioterapia con inmunoterapia celular autóloga en el cáncer colorrectal recidivante y metastásico	Fase Fase 3	Date Added 2019-05-15	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Bevacizumab Injection [Avastin], capecitabine, oxaliplatin, PD1-T cells	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03947385	TitleEstudio de IDE196 en pacientes con tumores sólidos portadores de mutaciones GNAQ/11 o fusiones PRKC	Fase Phase 1, Phase 2	Date Added 2019-05-13	Ubicación California, United States New York, United States North Carolina, United States Ohio, United States Pennsylvania, United States Tennessee, United States Texas, United States Australia Canadá	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Binimetinib, Crizotinib, IDE196	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03829462	TitleEvaluación de una combinación de regorafenib e irinotecán frente a regorafenib solo en pacientes con cáncer colorrectal metastásico	Fase Fase 3	Date Added 2019-02-04	Ubicación Francia	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Irinotecan, Regorafenib	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04014530	TitlePembrolizumab With Ataluren in Patients With Metastatic pMMR and dMMR Colorectal Carcinoma or Metastatic dMMR Endometrial Carcinoma: the ATAPEMBRO Study	Fase Fase 1	Date Added 2019-07-10	Ubicación Países Bajos	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Ataluren + Pembrolizumab, Keytruda	Etiquetas MSS/ MMRp
NCT ID NCT04096417	TitlePemigatinib for the Treatment of Metastatic or Unresectable Colorectal Cancer Harboring FGFR Alterations	Fase Fase 2	Date Added 2019-09-19	Ubicación Arizona, United States Georgia, United States Minnesota, United States North Carolina, United States Tennessee, United States Wisconsin, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Pemigatinib	Etiquetas MSS/ MMRp
NCT ID NCT04874259	TitleLT para metástasis hepáticas colorrectales no resecables	Fase No aplicable	Date Added 2021-05-05	Ubicación Corea, República de	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04595266	TitleQuimioembolización (Lifepearls-Irinotecan) en pacientes con cáncer colorrectal y enfermedad metastásica	Fase Fase 2	Date Added 2020-10-20	Ubicación España	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Anti-EGFR or Bevacizumab, FOLFOX regimen, LIVERPEARLS-Irinotecan	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT04589845	TitleEstudio de la plataforma TAPISTRY (Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You)	Fase Fase 2	Date Added 2020-10-19	Ubicación Alabama, United States Arizona, United States California, United States Colorado, United States Delaware, United States Florida, United States Georgia, United States Idaho, United States Illinois, United States Indiana, United States Maine, United States Maryland, United States Michigan, United States Minnesota, United States Missouri, United States Montana, United States Nebraska, United States Nevada, United States New Hampshire, United States New Jersey, United States New Mexico, United States New York, United States Ohio, United States Oregon, United States Pennsylvania, United States South Carolina, United States Tennessee, United States Texas, United States Washington, United States Wisconsin, United States Australia Bélgica Brasil Canadá China Dinamarca Francia Alemania Hong Kong Israel Italia Japón Corea, República de Nueva Zelanda Polonia Portugal Puerto Rico Singapur Sudáfrica España Suiza Taiwán Reino Unido	Prior IO Allowed No	CRC-directed No	Status Reclutamiento	Drogas Alectinib, Atezolizumab, Belvarafenib, Entrectinib, Idasanutlin, Inavolisib, Ipatasertib, Pralsetinib, Trastuzumab emtansine	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03310008	TitleDose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases	Fase Fase 1	Date Added 2017-10-16	Ubicación Bélgica	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas NKR-2 cells	Etiquetas MSS/ MMRp
NCT ID NCT03984578	TitleEstudio de la ventana de oportunidad en el cáncer colorrectal	Fase Fase 2	Date Added 2019-06-13	Ubicación Singapur	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Capecitabine/ 5-FU, CapeOX, Pembrolizumab, Eloxatin, Keytruda	Etiquetas MSI-H/ MMRd, MSS/ MMRp

Showing 191 to 200 of 299 entries